CAS 1061318-81-7

Debio-0932

Description:

Debio-0932, identified by its CAS number 1061318-81-7, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known for its role as a selective inhibitor of certain protein targets, which may contribute to its efficacy in treating specific diseases. The compound exhibits a unique structure that allows it to interact with biological systems, influencing various cellular pathways. Its solubility, stability, and bioavailability are critical factors that determine its pharmacokinetic properties. Additionally, Debio-0932 has undergone various preclinical and clinical evaluations to assess its safety and effectiveness. As with many investigational drugs, ongoing studies aim to elucidate its mechanism of action, optimal dosing regimens, and potential side effects. Overall, Debio-0932 represents a promising candidate in the realm of targeted therapies, reflecting the ongoing advancements in medicinal chemistry and drug development.

Debio 0932 ,CUDC-305

CAS: 1061318-81-7

Formula: C₂₂H₃₀N₆O₂S

Purity: 98%

Molecular weight: 442.5776

Ref: IN-DA008TOO

2-((6-(Dimethylamino)benzo[d][1,3]dioxol-5-yl)thio)-1-(2-(neopentylamino)ethyl)-1H-imidazo[4,5-c]pyridin-4-amine

CAS: 1061318-81-7

2-((6-(Dimethylamino)benzo[d][1,3]dioxol-5-yl)thio)-1-(2-(neopentylamino)ethyl)-1H-imidazo[4,5-c]pyridin-4-amine

Purity: 98%

Molecular weight: 442.59g/mol

Ref: 54-OR1074838

Debio 0932

CAS: 1061318-81-7

Debio 0932 (CUDC-305) is a Hsp9 inhibitor, apoptosis, and has the advantage of being orally available and cross the BBB for cancers NSCLC and neuroblastoma.

Formula: C₂₂H₃₀N₆O₂S

Purity: 98.98%

Color and Shape: Solid

Molecular weight: 442.58

Ref: TM-T15088

Debio 0932

CAS: 1061318-81-7

Debio 0932 is a peptide-based protein that has potent antitumor activity against solid tumors and has the potential to interact with tumor cells. This protein is a potent inhibitor of HSP90, which is an important cellular chaperone and regulator of cell growth. Debio 0932 has been shown to inhibit the proliferation of cancer cells in animal models and xenograft tumor growth in vitro. It is also able to induce an antitumor response in mice, leading to complete regression of established tumours. Debio 0932 has been shown to be active against all tested carcinoma cell lines, including those resistant to conventional chemotherapeutic agents such as doxorubicin.

Formula: C₂₂H₃₀N₆O₂S

Purity: Min. 95%

Molecular weight: 442.58 g/mol

Ref: 3D-LSB31881